Vacc-4x viewed as the most promising therapeutic vaccine candidate by US AIDS magazine

Oslo, 30 March 2011

In an article in the March issue of A&U Magazine, America’s AIDS magazine, a positive view on therapeutic vaccines is presented. In the article, Vacc-4x is profiled as the vaccine candidate furthest along in development, and the promising viral load results of Vacc-4x are considered as an indication that therapeutic vaccines may potentially decrease the need for HIV antiretrovirals (ART), postponing treatment and/or reducing the time spent on ART. The article is now available online on